MicroRNA-200 family modulation in distinct breast cancer phenotypes.
about
MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast CancerMicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast CancerSystematic enrichment analysis of microRNA expression profiling studies in endometriosisFunctional Role of the microRNA-200 Family in Breast Morphogenesis and NeoplasiaMicroRNAs and triple negative breast cancerMiR-200, a new star miRNA in human cancerKey nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancerThe microRNA-200 family: small molecules with novel roles in cancer development, progression and therapymiR-200b as a prognostic factor in breast cancer targets multiple members of RAB familyMetaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies.Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinomaRe-expression of miR-200c suppresses proliferation, colony formation and in vivo tumor growth of murine claudin-low mammary tumor cells.Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer.microRNA-141 regulates BMI1 expression and induces senescence in human diploid fibroblasts.Overexpression of microRNA-200c predicts poor outcome in patients with PR-negative breast cancer.Reduced expression of miR-200 family members contributes to antiestrogen resistance in LY2 human breast cancer cellsThe role of miR-200a in mammalian epithelial cell transformation.Glabridin attenuates the migratory and invasive capacity of breast cancer cells by activating microRNA-200c.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.Identification of estrogen receptor proteins in breast cancer cells using matrix-assisted laser desorption/ionization time of flight mass spectrometry (Review).Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis.An improved sequencing-based strategy to estimate locus-specific DNA methylation.SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancermiR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer.MicroRNA transcriptomes relate intermuscular adipose tissue to metabolic riskActivation of miR200 by c-Myb depends on ZEB1 expression and miR200 promoter methylationHigher expression of circulating miR-182 as a novel biomarker for breast cancer.Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer.The role of microRNAs in tumors.Aberrant DNA methylation of microRNA genes in human breast cancer - a critical appraisal.microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.MicroRNA-Mediated Post-Transcriptional Regulation of Epithelial to Mesenchymal Transition in Cancer.Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition.Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells.Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease.
P2860
Q26775086-4D2747F8-05B7-4EF2-B313-2B341DDBECE7Q26801108-A1A8F84A-D61D-4A7A-A242-323B6535CF5AQ26822881-247EB451-76A8-4C00-967C-76B6C1746579Q26861636-293440DD-D917-42C3-A012-E286AE94AAC3Q26862716-0B6B4A49-5DF9-4E6F-8FE5-A25A5A8BC96FQ27004023-3E5F53C0-C26F-4C71-9F79-99868039BD36Q28082679-1409C3CD-E3E4-4753-8BF4-FDC373AE55CEQ28083742-633ABD3F-038B-483B-812D-8EC67B75756FQ28394618-1BF3AF01-EA16-4DE3-9CEB-3184F20F5CD5Q30447049-C759E854-7181-40A5-908E-C6C5728AEE45Q33559304-75AA1AB2-EBCD-4FBA-94F1-15A3974DD690Q33609359-B97B9274-D91B-4A07-AA74-04857B6D448BQ33618841-0699FDBB-74EC-49C5-B79C-9B6FB288F3FDQ33962806-BE12FECA-A112-46B0-AFBF-D8E170C57AC8Q34038397-84BFFB28-CFE3-4EB8-AABE-428385ECCA57Q34351474-05B49B1F-9C71-4DE6-BEA8-388C476F4095Q34693000-FE4300AC-046C-46EF-AC40-728218A87481Q34917932-A49E1A49-2FED-4C02-A306-37D5AD26EAB8Q35051903-EAA62282-6A2D-49EC-9C63-4F8BEDE07A86Q35094742-A4B71A45-3569-4257-A829-4E896C758EA9Q35157380-19D312E3-EFFC-4E00-A9B9-CBBF0B660265Q35675544-3ADD65AC-2C6F-46ED-ACC1-D96F63C44BF1Q35782282-B8DC4ED1-EA2F-4ADA-AABB-64658CFC0E3EQ36132296-D6F04D80-DD1F-41EF-9D1E-0292C4017FE1Q36140898-DFF227B9-4D5C-44D9-A1D1-50D354F54D3DQ36586444-66F6D136-21F8-42C4-99CE-54FB51094F8BQ36820634-820D08BE-BD13-4954-9A84-246CD0842D6CQ37126203-0B95F758-C6AF-4A4C-97BB-506B92C613F4Q37326193-5771E3AC-4D27-4462-B11E-E9186F731890Q38081505-BB92DEE6-903E-45EF-A7F5-277AD5732BC8Q38123756-6CCE152D-AE7B-4AFF-A555-4E4B844B8C8DQ38186556-9F2C01F9-7375-42B3-989C-3B0FC29D5693Q38336073-8AD1D80E-10E0-445B-8EC7-53DD1CA73F5DQ38881055-0E5C6A6F-48FF-4F58-8850-3261E8091584Q38945186-AB39C51C-9244-43CF-8614-81765BEEEEA0Q39004454-36E79317-D86E-4F6D-9FA9-20B8A71317DFQ39079687-B636E0E7-8396-4603-A4F8-48B9298015A9Q39311503-5C36B650-D02F-4DAF-9985-AADAE068A80AQ41065670-344E11F1-0B7E-4EAE-843B-7A6F78989E08Q47701015-7AC3FCE9-A51A-4B10-9280-423431D5F542
P2860
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
@ast
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
@en
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
@nl
type
label
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
@ast
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
@en
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
@nl
prefLabel
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
@ast
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
@en
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
@nl
P2093
P2860
P1433
P1476
MicroRNA-200 family modulation in distinct breast cancer phenotypes.
@en
P2093
Begoña Vieites
Clare M Isacke
David Sarrió
José Palacios
Juan Díaz-Martín
María Ángeles Castilla
María Ángeles López-García
Michele Biscuola
Susana Ramiro-Fuentes
P2860
P304
P356
10.1371/JOURNAL.PONE.0047709
P407
P577
2012-10-24T00:00:00Z